Related Experiment Video
Updated: Feb 26, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Interventional approaches to deep venous thrombosis
Kristen A Lee1, Raja S Ramaswamy
1aDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California bSection of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University of St. Louis, Saint Louis, Missouri, USA.
Insights
Catheter-directed therapy (CDT) effectively removes deep vein thrombosis (DVT) and reduces postthrombotic syndrome. This endovascular approach offers a safe and beneficial treatment option for selected DVT patients.
Area of Science:
- Vascular Medicine
- Interventional Cardiology
- Thrombosis Management
Background:
- Anticoagulation alone is insufficient for some deep vein thrombosis (DVT) cases.
- Catheter-directed therapy (CDT) serves as an adjunct treatment for DVT.
- Endovascular management of DVT requires updated discussion on its efficacy and safety.
Purpose of the Study:
- To review the rationale for CDT in DVT.
- To discuss the safety profile of endovascular DVT management.
- To analyze clinical outcomes of CDT for DVT.
Main Methods:
- Review of early studies on catheter-directed thrombolysis (CDT).
- Analysis of the Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis trial.
- Inclusion of recent randomized trials and ongoing studies like the Acute Venous Thrombosis trial.
Main Results:
- CDT demonstrates success in rapid thrombus removal.
- CDT is associated with a lower incidence of postthrombotic syndrome (PTS).
- Long-term benefits of CDT are supported by 5-year follow-up data; pharmacomechanical CDT shows promise but requires further long-term efficacy studies.
Conclusions:
- Catheter-directed therapy is a well-tolerated treatment for selected acute proximal DVT patients.
- CDT offers significant reduction in PTS incidence.
- Ongoing trials will further define the role of pharmacomechanical CDT in DVT management.
Purpose Of Review:
Catheter-directed therapy in deep vein thrombosis (DVT) is a beneficial adjunct treatment when anticoagulation alone does not provide an adequate therapeutic response. This review aims to deliver an up-to-date discussion behind the rationale, safety profile, and clinical outcomes in endovascular management of DVT.
Recent Findings:
Early studies have shown that the use of catheter-directed thrombolysis (CDT) to be successful in rapid thrombus removal, carry a lower incidence of postthrombotic syndrome (PTS), and improved quality of life. To date, the most robust study evaluating the use of CDT is the Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis trial published in 2012, which demonstrated a relative risk reduction in PTS of 26% in the patients who received CDT at 2-year follow-up. The 5-year follow-up results from the trial has recently been published, which revealed persistent clinical benefit of CDT. Since, additional small randomized trials confer the efficacy and safety profile of CDT. Short-term results from pharmacomechanical catheter-directed thrombolysis are promising; however, the long-term efficacy has yet to be established. The recently completed Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis trial will be a pivotal study in defining the future role of pharmacomechanical catheter-directed thrombolysis in prevention of PTS.
Summary:
CDT is a reasonable and well tolerated treatment option in selected patients with acute proximal DVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

